ARCHIVES

NY Federal Court Rules Against Myriad, Finding Patents On Genes Unlawful.

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | April 2, 2010

Download PDF Visit The Full Archive

Related Articles

In Brief: Litton Bionetic’s New contract For Operation of FCRC Total $128.8 Million For Five Years

October 7, 1977

Genentech’s Ferrara Wins Lasker Award For VEGF Discovery

October 8, 2010

Daily Humidification Improves Quality-of-Life in Phase III Trial

February 28, 2014

Low Dose DFMO Reduces Colon Adenoma Recurrence

April 25, 2008

In Brief: Ireland Cancer Center Named Comprehensive; UPCI Appoints Four Program Directors

February 27, 1998

Analyzing Tumor Tissue In Clinical Trials Can Improve Outcomes, RTOG Trial Finds

May 27, 2011